The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are up 178%. Our forward projection puts the odds of a 10% gain over the next month near 27%.
Xiao-I Corp ADR
AIXI · NASDAQ · USD · Market cap $1M · 58 employees
Xiao-I Corporation, through its subsidiary, Shanghai Xiao-i Robot Technology Co., Ltd., provides software services in the People's Republic of China.
FAIL · Does not pass the screenScreen close, 2026-09-21 · not a live quote
Screened 2026-09-21 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 1.88 against the desk's fair-value range, over the last year.
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Xiao-I Corp ADR holds its Markup at $1.88. The statistical read favours the sellers, held for 7 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 7 days |
| Price at the screen | $1.88 |
| Valuation | N/A trailing · -2.85 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 14.76 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 294.19% | Below 33% | Interest-bearing debt is 294.2% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 54.27% | Below 49% | Money owed to the company is 54.3% of assets, above the 49% limit. | Fail |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Business, in Plain Words| Forward P/E | -2.9x |
| EPS, trailing | -146.40 |
| EPS, forward | -0.54 |
| Revenue growth | -97.8%revenue is shrinking |
| Profit margin | 0.0%currently unprofitable |
| FCF yield | 1,974.66% |
| Current ratio | 0.12below 1: short-term bills exceed liquid assets |
| Beta | 14.76much more volatile than the market |
| 52-week range | 1.53 - 54.20 |
| Moat | NONE |
| Market cap | $1M |
| Employees | 58 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeAIXI trades on NASDAQ (the company is based in China). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are up 178%. Our forward projection puts the odds of a 10% gain over the next month near 27%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 80.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 178%. Our forward projection puts the odds of a 10% gain over the next month near 27%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 178%. Our forward projection puts the odds of a 10% gain over the next month near 27%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 178%. Our forward projection puts the odds of a 10% gain over the next month near 27%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $11.73 | -32.0% | · | $680 | -32.0% |
| 2 months | $1.22 | +553.7% | · | $6,537 | +553.7% |
| 3 months | $0.20 | +3,848.0% | · | $39,480 | +3,848.0% |
| 6 months | $0.61 | +1,201.0% | · | $13,010 | +1,201.0% |
| 1 year | $2.87 | +177.9% | · | $2,779 | +177.9% |
| 2 years | $7.62 | +4.6% | · | $1,046 | +4.6% |
| 3 years | $50.31 | -84.2% | · | $159 | -84.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever AIXI does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.